Zanamivir for the treatment of influenza in adults: a systematic review and economic evaluation.
Burls
A
A
Department of Public Health and Epidemiology, University of Birmingham, UK.
Clark
W
W
Stewart
T
T
Preston
C
C
Bryan
S
S
Jefferson
T
T
Fry-Smith
A
A
D000328:Adult; D000998:Antiviral Agents / Q000009:adverse effects / Q000191:economics* / Q000627:therapeutic use*; D003362:Cost-Benefit Analysis; D006146:Guanidines; D006801:Humans; D007251:Influenza, Human / Q000188:drug therapy*; D011714:Pyrans; D016032:Randomized Controlled Trials as Topic; D012794:Sialic Acids / Q000009:adverse effects / Q000191:economics* / Q000627:therapeutic use*; D016896:Treatment Outcome; D006113:United Kingdom; D053243:Zanamivir
D000998:Antiviral Agents; D006146:Guanidines; D011714:Pyrans; D012794:Sialic Acids; D053243:Zanamivir